PRESS DIGEST - Wall Street Journal - April 25
April 25 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
Jan 9 Gilead Sciences
* CEO says planning Phase III trials of NASH drug in patients with advanced fibrosis Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)
FRANKFURT, April 25 The following are some of the factors that may move German stocks on Tuesday: